Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apevinat BC vs Vitamin Complex for Appetite Stimulation
NCT01295450Phase 3Unknown
- Sponsor
- MDC Pharmaceuticals
- Start
- Apr 2011
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of cyproheptadine in anorexia nervosa (AN) (2 arms), sponsored by MDC Pharmaceuticals. Primary endpoint: Effectiveness of Apevinat BC in appetite stimulation at 30 days. Status: unknown.
02
Drugs
cyproheptadine
03
Conditions
anorexia nervosa (AN)
Beyond the preview
Go deeper on NCT01295450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01295450.